Evaluation of the safety and immunological effects of Bacillus Calmette–Guérin in combination with checkpoint inhibitor therapy in a patient with neuroendocrine carcinoma: a case report

BACKGROUND: Immune checkpoint inhibitors have revolutionized therapy of advanced and metastatic cancers. However, a significant proportion of patients do not respond to immune checkpoint inhibitors or develop resistance. Therefore, novel therapies or combinations of therapies that may act synergisti...

Descripción completa

Detalles Bibliográficos
Autores principales: Föhse, Konstantin, Debisarun, Priya A., Kilic, Gizem, van Dodewaard-de Jong, Joyce M., Netea, Mihai G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476294/
https://www.ncbi.nlm.nih.gov/pubmed/37661259
http://dx.doi.org/10.1186/s13256-023-04117-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476294/
https://www.ncbi.nlm.nih.gov/pubmed/37661259
http://dx.doi.org/10.1186/s13256-023-04117-3

Ejemplares similares